
NATURE . COM {
}
Title:
A phase II trial with rosiglitazone in liposarcoma patients | British Journal of Cancer
Description:
Agents of the thiazolidinedione drug family can terminally differentiate human liposarcoma cells in vitro by activating genes responsible for lipocyte differentiation. One study has shown clinical activity of troglitazone treatment in liposarcoma patients. We sought to find further evidence for this result. In all, 12 patients with a liposarcoma received rosiglitazone 4 mg b.d. They were followed clinically and with repeated biopsies for histological and biological studies. At the molecular level the mRNA translation of three genes that are induced by this treatment (peroxisome proliferator-activated receptor γ (PPARγ), adipsin and fatty acid binding protein) was determined. Nine patients were eligible for evaluation. One patient had to stop treatment due to hepatotoxicity. The mean time to progression was 6 months (2 – 16 months), with one patient still on treatment. We did not see any significant change in histologic appearance of the liposarcomas by the treatment. The level of gene expression changed significantly in two patients, but this did not result in a clinical response. Based on this study, rosiglitazone is not effective as an antitumoral drug in the treatment of liposarcomas. Increased PPARγ activity does not correlate with the clinical evolution.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.
Keywords {🔍}
patients, liposarcoma, pparγ, treatment, pubmed, article, google, scholar, cancer, cas, nature, rosiglitazone, clinical, liposarcomas, human, expression, patient, gene, differentiation, molecular, peroxisome, proliferatoractivated, receptor, tumour, cells, study, months, cell, tontonoz, gamma, analysis, data, troglitazone, spiegelman, leuven, level, fletcher, cookies, content, trial, genes, biological, adipsin, protein, myxoid, fusion, activation, performed, probe, privacy,
Topics {✒️}
nature portfolio privacy policy peroxisome proliferator-activated receptor-γ peroxisome-proliferator activated receptor-gamma advertising nature 363 nature soft-tissue sarcoma—gold standard social media peroxisome proliferator-activated receptors author information authors 0/ reprints lipid-activated transcription factor pax8-ppargamma1 fusion oncogene author correspondence tls-chop fusion protein ews-chop fusion transcript ultrasound-guided needle biopsy full size image permissions myxoid/round cell subtypes inhibit tumour growth myxoid/round cell liposarcomas high affinity ligand soft tissue simulators privacy 14 october 2003 rna-binding protein primary tumour sample dei tos utilising standard procedures explore content tissue-specific regulator journals search log solid tumor differentiation human colon cancer metastastic colon cancer van den bh human myxoid liposarcoma round cell liposarcoma cellular proliferation rates european economic area personal data meis-kindblom giant marker chromosomes chromosomal region 12q spring-driven device quantify mrna levels glyceraldehyde-3-phosphate dehydrogenase g-banded chromosomes
Schema {🗺️}
WebPage:
mainEntity:
headline:A phase II trial with rosiglitazone in liposarcoma patients
description:Agents of the thiazolidinedione drug family can terminally differentiate human liposarcoma cells in vitro by activating genes responsible for lipocyte differentiation. One study has shown clinical activity of troglitazone treatment in liposarcoma patients. We sought to find further evidence for this result. In all, 12 patients with a liposarcoma received rosiglitazone 4âmg b.d. They were followed clinically and with repeated biopsies for histological and biological studies. At the molecular level the mRNA translation of three genes that are induced by this treatment (peroxisome proliferator-activated receptor γ (PPARγ), adipsin and fatty acid binding protein) was determined. Nine patients were eligible for evaluation. One patient had to stop treatment due to hepatotoxicity. The mean time to progression was 6 months (2âââ16 months), with one patient still on treatment. We did not see any significant change in histologic appearance of the liposarcomas by the treatment. The level of gene expression changed significantly in two patients, but this did not result in a clinical response. Based on this study, rosiglitazone is not effective as an antitumoral drug in the treatment of liposarcomas. Increased PPARγ activity does not correlate with the clinical evolution.
datePublished:2003-10-14T00:00:00Z
dateModified:2011-11-16T00:00:00Z
pageStart:1409
pageEnd:1412
sameAs:https://doi.org/10.1038/sj.bjc.6601306
keywords:
liposarcoma
rosiglitazone
PPARγ
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6601306/MediaObjects/41416_2003_Article_BF6601306_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6601306/MediaObjects/41416_2003_Article_BF6601306_Fig2_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:89
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:G Debrock
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:V Vanhentenrijk
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:R Sciot
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:M Debiec-Rychter
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Human Genetics, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:R Oyen
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Radiology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:A Van Oosterom
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A phase II trial with rosiglitazone in liposarcoma patients
description:Agents of the thiazolidinedione drug family can terminally differentiate human liposarcoma cells in vitro by activating genes responsible for lipocyte differentiation. One study has shown clinical activity of troglitazone treatment in liposarcoma patients. We sought to find further evidence for this result. In all, 12 patients with a liposarcoma received rosiglitazone 4âmg b.d. They were followed clinically and with repeated biopsies for histological and biological studies. At the molecular level the mRNA translation of three genes that are induced by this treatment (peroxisome proliferator-activated receptor γ (PPARγ), adipsin and fatty acid binding protein) was determined. Nine patients were eligible for evaluation. One patient had to stop treatment due to hepatotoxicity. The mean time to progression was 6 months (2âââ16 months), with one patient still on treatment. We did not see any significant change in histologic appearance of the liposarcomas by the treatment. The level of gene expression changed significantly in two patients, but this did not result in a clinical response. Based on this study, rosiglitazone is not effective as an antitumoral drug in the treatment of liposarcomas. Increased PPARγ activity does not correlate with the clinical evolution.
datePublished:2003-10-14T00:00:00Z
dateModified:2011-11-16T00:00:00Z
pageStart:1409
pageEnd:1412
sameAs:https://doi.org/10.1038/sj.bjc.6601306
keywords:
liposarcoma
rosiglitazone
PPARγ
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6601306/MediaObjects/41416_2003_Article_BF6601306_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6601306/MediaObjects/41416_2003_Article_BF6601306_Fig2_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:89
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:G Debrock
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:V Vanhentenrijk
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:R Sciot
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:M Debiec-Rychter
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Human Genetics, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:R Oyen
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Radiology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
name:A Van Oosterom
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:89
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Human Genetics, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Radiology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:G Debrock
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
email:[email protected]
name:V Vanhentenrijk
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
name:R Sciot
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
name:M Debiec-Rychter
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Human Genetics, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
name:R Oyen
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Radiology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
name:A Van Oosterom
affiliation:
name:University Hospital Gasthuisberg, Universiteit Leuven
address:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
name:Department of Pathology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
name:Department of Human Genetics, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
name:Department of Radiology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
name:Department of Medical Oncology, University Hospital Gasthuisberg, Universiteit Leuven, Leuven, Belgium
External Links {🔗}(83)
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11751490 gross monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20p53%20status%2C%20TLS-CHOP%20fusion%20transcript%20structure%2C%20and%20histological%20grade%20in%20myxoid%20liposarcoma%3A%20a%20molecular%20and%20clinicopathologic%20study%20of%2082%20cases&journal=Clin%20Cancer%20Res&volume=7&pages=3977-3987&publication_year=2001&author=Antonescu%2CCR&author=Tschernyavsky%2CSJ&author=Decuseara%2CR&author=Leung%2CDH&author=Woodruff%2CJM&author=Brennan%2CMF&author=Bridge%2CJA&author=Neff%2CJR&author=Goldblum%2CJR&author=Ladanyi%2CM?
- Get to know what's the income of https://doi.org/10.1016%2FS0024-3205%2802%2901510-2
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12269390
- How much profit does http://scholar.google.com/scholar_lookup?&title=Apoptosis%20induced%20by%20activation%20of%20peroxisome-proliferator%20activated%20receptor-gamma%20is%20associated%20with%20Bcl-2%20and%20NF-kappaB%20in%20human%20colon%20cancer&journal=Life%20Sci&doi=10.1016%2FS0024-3205%2802%2901510-2&volume=70&pages=2631-2646&publication_year=2002&author=Chen%2CGG&author=Lee%2CJF&author=Wang%2CSH&author=Chan%2CUP&author=Ip%2CPC&author=Lau%2CWY generate?
- What is the earnings of https://doi.org/10.1038%2F363640a0?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8510758?
- Get to know http://scholar.google.com/scholar_lookup?&title=Fusion%20of%20CHOP%20to%20a%20novel%20RNA-binding%20protein%20in%20human%20myxoid%20liposarcoma&journal=Nature&doi=10.1038%2F363640a0&volume=363&pages=640-644&publication_year=1993&author=Crozat%2CA&author=Aman%2CP&author=Mandahl%2CN&author=Ron%2CD's earnings
- How much does https://doi.org/10.1053%2Fadpa.2000.8133 pull in?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Liposarcoma%3A%20new%20entities%20and%20evolving%20concepts&journal=Ann%20Design%20Pathol&doi=10.1053%2Fadpa.2000.8133&volume=4&pages=252-266&publication_year=2000&author=Dei%20Tos%2CAP
- What are the earnings of https://doi.org/10.1073%2Fpnas.96.7.3951?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10097144 makes per month
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC22401
- How much profit does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20solid%20tumor%20differentiation%20by%20the%20peroxisome%20proliferator-activated%20receptor-gamma%20ligand%20troglitazone%20in%20patients%20with%20liposarcoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.96.7.3951&volume=96&pages=3951-3956&publication_year=1999&author=Demetri%2CGD&author=Fletcher%2CCD&author=Mueller%2CE&author=Sarraf%2CP&author=Naujoks%2CR&author=Campbell%2CN&author=Spiegelman%2CBM&author=Singer%2CS generate?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10954962?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Rosiglitazone&journal=Int%20J%20Clin%20Pract&volume=54&pages=333-337&publication_year=2000&author=Goldstein%2CBJ have monthly?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11431375?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Mutational%20analysis%20of%20the%20peroxisome%20proliferator-activated%20receptor%20gamma%20gene%20in%20human%20malignancies&journal=Cancer%20Res&volume=61&pages=5307-5310&publication_year=2001&author=Ikezoe%2CT&author=Miller%2CCW&author=Kawano%2CS&author=Heaney%2CA&author=Williamson%2CEA&author=Hisatake%2CJ&author=Green%2CE&author=Hofmann%2CW&author=Taguchi%2CH&author=Koeffler%2CHP earns monthly
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7805034
- Earnings of http://scholar.google.com/scholar_lookup?&title=Translocation%20t%2812%3B16%29%28q13%3Bp11%29%20in%20myxoid%20liposarcoma%20and%20round%20cell%20liposarcoma%3A%20molecular%20and%20cytogenetic%20analysis&journal=Cancer%20Res&volume=55&pages=24-27&publication_year=1995&author=Knight%2CJC&author=Renwick%2CPJ&author=Cin%2CPD&author=Van%20den%2CBH&author=Fletcher%2CCD
- What are the earnings of https://doi.org/10.1126%2Fscience.289.5483.1357?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10958784?
- Revenue of http://scholar.google.com/scholar_lookup?&title=PAX8-PPARgamma1%20fusion%20oncogene%20in%20human%20thyroid%20carcinoma%20%5Bcorrected%5D&journal=Science&doi=10.1126%2Fscience.289.5483.1357&volume=289&pages=1357-1360&publication_year=2000&author=Kroll%2CTG&author=Sarraf%2CP&author=Pecciarini%2CL&author=Chen%2CCJ&author=Mueller%2CE&author=Spiegelman%2CBM&author=Fletcher%2CJA
- What are the total earnings of https://doi.org/10.1097%2F00130404-200209000-00010?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12416897 makes per month
- See how much http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20of%20troglitazone%2C%20an%20activator%20of%20the%20PPARgamma%20receptor%2C%20in%20patients%20with%20chemotherapy-resistant%20metastatic%20colorectal%20cancer&journal=Cancer%20J&doi=10.1097%2F00130404-200209000-00010&volume=8&pages=395-399&publication_year=2002&author=Kulke%2CMH&author=Demetri%2CGD&author=Sharpless%2CNE&author=Ryan%2CDP&author=Shivdasani%2CR&author=Clark%2CJS&author=Spiegelman%2CBM&author=Kim%2CH&author=Mayer%2CRJ&author=Fuchs%2CCS makes per month
- What's https://doi.org/10.1074%2Fjbc.270.22.12953's gross income?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7768881 make?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=An%20antidiabetic%20thiazolidinedione%20is%20a%20high%20affinity%20ligand%20for%20peroxisome%20proliferator-activated%20receptor%20gamma%20%28PPAR%20gamma%29&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.270.22.12953&volume=270&pages=12953-12956&publication_year=1995&author=Lehmann%2CJM&author=Moore%2CLB&author=Smith-Oliver%2CTA&author=Wilkison%2CWO&author=Willson%2CTM&author=Kliewer%2CSA
- How much profit does https://link.springer.com/doi/10.1007/s004280100423 make?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11561754?
- How much does http://scholar.google.com/scholar_lookup?&title=Cytogenetic%20and%20molecular%20genetic%20analyses%20of%20liposarcoma%20and%20its%20soft%20tissue%20simulators%3A%20recognition%20of%20new%20variants%20and%20differential%20diagnosis&journal=Virchows%20Arch&doi=10.1007%2Fs004280100423&volume=439&pages=141-151&publication_year=2001&author=Meis-Kindblom%2CJM&author=Sjogren%2CH&author=Kindblom%2CLG&author=Peydro-Mellquist%2CA&author=Roijer%2CE&author=Aman%2CP&author=Stenman%2CG bring in each month?
- How much income is http://scholar.google.com/scholar_lookup?&title=ISCN.%20An%20International%20System%20for%20Human%20Genetic%20Nomenclature&publication_year=1995&author=Mitelman%2CF earning monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11507074 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Anticancer%20effects%20of%20thiazolidinediones%20are%20independent%20of%20peroxisome%20proliferator-activated%20receptor%20gamma%20and%20mediated%20by%20inhibition%20of%20translation%20initiation&journal=Cancer%20Res&volume=61&pages=6213-6218&publication_year=2001&author=Palakurthi%2CSS&author=Aktas%2CH&author=Grubissich%2CLM&author=Mortensen%2CRM&author=Halperin%2CJA income
- How much cash flow does https://doi.org/10.1172%2FJCI0215634 have monthly?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12370270?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151148?
- Revenue of http://scholar.google.com/scholar_lookup?&title=PPARgamma%20ligands%20inhibit%20primary%20tumor%20growth%20and%20metastasis%20by%20inhibiting%20angiogenesis&journal=J%20Clin%20Invest&doi=10.1172%2FJCI0215634&volume=110&pages=923-932&publication_year=2002&author=Panigrahy%2CD&author=Singer%2CS&author=Shen%2CLQ&author=Butterfield%2CCE&author=Freedman%2CDA&author=Chen%2CEJ&author=Moses%2CMA&author=Kilroy%2CS&author=Duensing%2CS&author=Fletcher%2CC&author=Fletcher%2CJA&author=Hlatky%2CL&author=Hahnfeldt%2CP&author=Folkman%2CJ&author=Kaipainen%2CA
- Get to know https://doi.org/10.1016%2FS1097-2765%2801%2980012-5's earnings
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10394368 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20mutations%20in%20PPAR%20gamma%20associated%20with%20human%20colon%20cancer&journal=Mol%20Cell&doi=10.1016%2FS1097-2765%2801%2980012-5&volume=3&pages=799-804&publication_year=1999&author=Sarraf%2CP&author=Mueller%2CE&author=Smith%2CWM&author=Wright%2CHM&author=Kum%2CJB&author=Aaltonen%2CLA&author=de%20la%2CCA&author=Spiegelman%2CBM&author=Eng%2CC pull in monthly?
- What's the profit of https://doi.org/10.1128%2FMCB.15.1.351?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7799943's financial summary
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC231968?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=PPAR%20gamma%202%20regulates%20adipose%20expression%20of%20the%20phosphoenolpyruvate%20carboxykinase%20gene&journal=Mol%20Cell%20Biol&doi=10.1128%2FMCB.15.1.351&volume=15&pages=351-357&publication_year=1995&author=Tontonoz%2CP&author=Hu%2CE&author=Devine%2CJ&author=Beale%2CEG&author=Spiegelman%2CBM
- Get to know https://doi.org/10.1101%2Fgad.8.10.1224's earnings
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7926726
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=mPPAR%20gamma%202%3A%20tissue-specific%20regulator%20of%20an%20adipocyte%20enhancer&journal=Genes%20Dev&doi=10.1101%2Fgad.8.10.1224&volume=8&pages=1224-1234&publication_year=1994&author=Tontonoz%2CP&author=Hu%2CE&author=Graves%2CRA&author=Budavari%2CAI&author=Spiegelman%2CBM
- How much revenue does https://doi.org/10.1016%2F0092-8674%2894%2990006-X bring in?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8001151?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Stimulation%20of%20adipogenesis%20in%20fibroblasts%20by%20PPAR%20gamma%202%2C%20a%20lipid-activated%20transcription%20factor&journal=Cell&doi=10.1016%2F0092-8674%2894%2990006-X&volume=79&pages=1147-1156&publication_year=1994&author=Tontonoz%2CP&author=Hu%2CE&author=Spiegelman%2CBM?
- Revenue of https://doi.org/10.1073%2Fpnas.94.1.237
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8990192
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC19300?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Terminal%20differentiation%20of%20human%20liposarcoma%20cells%20induced%20by%20ligands%20for%20peroxisome%20proliferator-activated%20receptor%20gamma%20and%20the%20retinoid%20X%20receptor&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.94.1.237&volume=94&pages=237-241&publication_year=1997&author=Tontonoz%2CP&author=Singer%2CS&author=Forman%2CBM&author=Sarraf%2CP&author=Fletcher%2CJA&author=Fletcher%2CCD&author=Brun%2CRP&author=Mueller%2CE&author=Altiok%2CS&author=Oppenheim%2CH&author=Evans%2CRM&author=Spiegelman%2CBM?
- https://doi.org/10.1016%2FS0140-6736%2898%2910364-1's financial summary
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10408502's revenue stream
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Medical%20significance%20of%20peroxisome%20proliferator-activated%20receptors&journal=Lancet&doi=10.1016%2FS0140-6736%2898%2910364-1&volume=354&pages=141-148&publication_year=1999&author=Vamecq%2CJ&author=Latruffe%2CN
- How much profit is https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6601306?format=refman&flavour=references making per month?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20Debrock earns monthly
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20Debrock%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=V%20Vanhentenrijk is on a monthly basis
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22V%20Vanhentenrijk%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20Sciot produce monthly?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20Sciot%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20Debiec-Rychter each month?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20Debiec-Rychter%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20Oyen
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20Oyen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Van%20Oosterom?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Van%20Oosterom%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- https://s100.copyright.com/AppDispatchServlet?title=A%20phase%20II%20trial%20with%20rosiglitazone%20in%20liposarcoma%20patients&author=G%20Debrock%20et%20al&contentID=10.1038%2Fsj.bjc.6601306©right=The%20Author%28s%29&publication=0007-0920&publicationDate=2003-10-14&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-SA's revenue stream
- What's the total monthly financial gain of https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6601306?format=refman&flavour=citation?
- How much profit is https://doi.org/10.1186/s12885-022-09379-6 making per month?
- How much does https://doi.org/10.1186/s12944-021-01593-8 earn?
- Discover the revenue of https://doi.org/10.1186/s12885-016-2524-6
- How much does https://doi.org/10.1038/nrclinonc.2014.26 make?
- Explore the financials of https://doi.org/10.1038/nrc3214
- Get to know https://www.protocols.io/'s earnings
- How much money does https://www.natureindex.com/ generate?
- What's the income of http://www.naturechina.com?
- How much revenue does https://www.natureasia.com/ja-jp bring in?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref